162 related articles for article (PubMed ID: 22047406)
1. YY1 overexpression is associated with poor prognosis and metastasis-free survival in patients suffering osteosarcoma.
de Nigris F; Zanella L; Cacciatore F; De Chiara A; Fazioli F; Chiappetta G; Apice G; Infante T; Monaco M; Rossiello R; De Rosa G; Alberghini M; Napoli C
BMC Cancer; 2011 Nov; 11():472. PubMed ID: 22047406
[TBL] [Abstract][Full Text] [Related]
2. Expression of transcription factor Yin Yang 1 in human osteosarcomas.
de Nigris F; Botti C; de Chiara A; Rossiello R; Apice G; Fazioli F; Fiorito C; Sica V; Napoli C
Eur J Cancer; 2006 Oct; 42(15):2420-4. PubMed ID: 16962318
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 overexpression predicts poor survival in patients with high-grade extremity osteosarcoma: a pilot study.
Urakawa H; Nishida Y; Naruse T; Nakashima H; Ishiguro N
Clin Orthop Relat Res; 2009 Nov; 467(11):2932-8. PubMed ID: 19326179
[TBL] [Abstract][Full Text] [Related]
4. Cooperation between Myc and YY1 provides novel silencing transcriptional targets of alpha3beta1-integrin in tumour cells.
de Nigris F; Botti C; Rossiello R; Crimi E; Sica V; Napoli C
Oncogene; 2007 Jan; 26(3):382-94. PubMed ID: 16878156
[TBL] [Abstract][Full Text] [Related]
5. Deletion of Yin Yang 1 protein in osteosarcoma cells on cell invasion and CXCR4/angiogenesis and metastasis.
de Nigris F; Rossiello R; Schiano C; Arra C; Williams-Ignarro S; Barbieri A; Lanza A; Balestrieri A; Giuliano MT; Ignarro LJ; Napoli C
Cancer Res; 2008 Mar; 68(6):1797-808. PubMed ID: 18339860
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of relaxin-2 and S100A4 expression in osteosarcoma.
Huang H; Zheng HY; Liu ZL; Zhang L
Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2828-34. PubMed ID: 25339476
[TBL] [Abstract][Full Text] [Related]
7. pFAK-Y397 overexpression as both a prognostic and a predictive biomarker for patients with metastatic osteosarcoma.
Thanapprapasr K; Nartthanarung A; Thanapprapasr D; Jinawath A
PLoS One; 2017; 12(8):e0182989. PubMed ID: 28846700
[TBL] [Abstract][Full Text] [Related]
8. Elevated Expression of Transforming Acidic Coiled-Coil Containing Protein 3 (TACC3) Is Associated With a Poor Prognosis in Osteosarcoma.
Matsuda K; Miyoshi H; Hiraoka K; Hamada T; Nakashima K; Shiba N; Ohshima K
Clin Orthop Relat Res; 2018 Sep; 476(9):1848-1855. PubMed ID: 30024460
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of immunohistochemical expression of ezrin in non-metastatic high-grade osteosarcoma.
Ferrari S; Zanella L; Alberghini M; Palmerini E; Staals E; Bacchini P
Pediatr Blood Cancer; 2008 Apr; 50(4):752-6. PubMed ID: 17886294
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of resistance-related proteins (metallothioneins, glutathione-S-transferase pi, heat shock protein 27, and lung resistance-related protein) in osteosarcoma. Relationship with poor prognosis.
Uozaki H; Horiuchi H; Ishida T; Iijima T; Imamura T; Machinami R
Cancer; 1997 Jun; 79(12):2336-44. PubMed ID: 9191521
[TBL] [Abstract][Full Text] [Related]
11. Vitronectin significantly influences prognosis in osteosarcoma.
Shi K; Lan RL; Tao X; Wu CY; Hong HF; Lin JH
Int J Clin Exp Pathol; 2015; 8(9):11364-71. PubMed ID: 26617861
[TBL] [Abstract][Full Text] [Related]
12. YY1 expression predicts favourable outcome in follicular lymphoma.
Naidoo K; Clay V; Hoyland JA; Swindell R; Linton K; Illidge T; Radford JA; Byers RJ
J Clin Pathol; 2011 Feb; 64(2):125-9. PubMed ID: 21109702
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of blood and urinary angiogenic factor levels at diagnosis and during treatment in patients with osteosarcoma: a prospective study.
Tabone MD; Brugières L; Piperno-Neumann S; Selva MA; Marec-Bérard P; Pacquement H; Lervat C; Corradini N; Gentet JC; Couderc R; Chevance A; Mahier-Ait Oukhatar C; Entz-Werle N; Blay JY; Le Deley MC
BMC Cancer; 2017 Jun; 17(1):419. PubMed ID: 28619014
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.
Robl B; Pauli C; Botter SM; Bode-Lesniewska B; Fuchs B
BMC Cancer; 2015 May; 15():379. PubMed ID: 25956431
[TBL] [Abstract][Full Text] [Related]
15. Expression of CD44 variants in osteosarcoma.
Kuryu M; Ozaki T; Nishida K; Shibahara M; Kawai A; Inoue H
J Cancer Res Clin Oncol; 1999 Nov; 125(11):646-52. PubMed ID: 10541973
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA LINC01578 drives colon cancer metastasis through a positive feedback loop with the NF-κB/YY1 axis.
Liu J; Zhan Y; Wang J; Wang J; Guo J; Kong D
Mol Oncol; 2020 Dec; 14(12):3211-3233. PubMed ID: 33040438
[TBL] [Abstract][Full Text] [Related]
17. XB130 expression in human osteosarcoma: a clinical and experimental study.
Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Trps1 contributes to tumor angiogenesis and poor prognosis of human osteosarcoma.
Li Z; Jia M; Wu X; Cui J; Pan A; Li L
Diagn Pathol; 2015 Sep; 10():167. PubMed ID: 26377811
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of microRNA-26a is associated with metastatic potential and the poor prognosis of osteosarcoma patients.
Song QC; Shi ZB; Zhang YT; Ji L; Wang KZ; Duan DP; Dang XQ
Oncol Rep; 2014 Mar; 31(3):1263-70. PubMed ID: 24452597
[TBL] [Abstract][Full Text] [Related]
20. Ephrin A4 expression in osteosarcoma, impact on prognosis, and patient outcome.
Abdou AG; Abd el-Wahed MM; Asaad NY; Samaka RM; Abdallaha R
Indian J Cancer; 2010; 47(1):46-52. PubMed ID: 20071790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]